🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Neurogene Inc.

NGNE Healthcare
$39.48 +$3.81 (10.68%)
Market Cap: $790.05 M
Gurus Holding
4
Popularity Rank
#2209
% of Shares Held
1.59%
Net Activity (Q2 2026)
+$8.34 M

Guru Ownership Trend

Guru Analysis for Neurogene Inc. (NGNE)

Neurogene Inc. (NGNE), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $12.59 M.

Top institutional holders include Steven Cohen and Louis Moore Bacon.

Institutional sentiment is currently Bullish. This is evidenced by a $8.34 M net inflow during the quarter.

Recent activity highlights Steven Cohen who opened a new position. Conversely, Renaissance Technologies (RenTech) reduced exposure by 53.0%.

Key Holders

Top 5 by Value

Recent Activity Breakdown (Q2 2026)

+$9.07 M
Total Buy Value
New Buys 2
Additions 1
-$723,192.47
Total Sell Value
Reductions 1
Sold Out 0

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
1
Net Buyers
3

FAQs for Neurogene Inc. (NGNE)

Major holders include Steven Cohen ($4.46 M), Louis Moore Bacon ($4.45 M), Renaissance Technologies (RenTech) ($641,737). According to the latest reported data, 4 tracked investment managers collectively hold approximately 319,022 shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $8.34 M, with 3 managers increasing positions and 1 managers reducing holdings.

During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited NGNE. The total reported sell value was $723,192.47.

Yes, 2 managers opened new positions in NGNE, and 1 increased their existing holdings. The total reported buy value was $9.07 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.00% New Buy 141,920 $4.46 M Q2 2026
0.07% New Buy 141,636 $4.45 M Q2 2026
0.00% Reduce -53.0% 20,405 $641,737 Q2 2026
0.00% Add 46.1% 15,061 $473,668 Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form